Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery

The lack of engineering systems able to faithfully reproduce complex kidney structures in vitro has made it difficult to efficiently model kidney diseases and development. Using polydimethylsiloxane (PDMS) scaffolds and a kidney-derived cell line we developed a system to rapidly engineer custom-made...

Full description

Bibliographic Details
Main Authors: Valentina Benedetti, Valerio Brizi, Patrizia Guida, Susanna Tomasoni, Osele Ciampi, Elena Angeli, Ugo Valbusa, Ariela Benigni, Giuseppe Remuzzi, Christodoulos Xinaris
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S235239641830207X
id doaj-483f9c49b79b441694f3786eaf80902b
record_format Article
spelling doaj-483f9c49b79b441694f3786eaf80902b2020-11-25T00:06:58ZengElsevierEBioMedicine2352-39642018-07-0133253268Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug DiscoveryValentina Benedetti0Valerio Brizi1Patrizia Guida2Susanna Tomasoni3Osele Ciampi4Elena Angeli5Ugo Valbusa6Ariela Benigni7Giuseppe Remuzzi8Christodoulos Xinaris9IRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, ItalyNanomed Laboratories, Dipartimento di Fisica, Università di Genova, 16146 Genova, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, ItalyNanomed Laboratories, Dipartimento di Fisica, Università di Genova, 16146 Genova, ItalyNanomed Laboratories, Dipartimento di Fisica, Università di Genova, 16146 Genova, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, Italy; ‘L. Sacco’ Department of Biomedical and Clinical Sciences, University of Milan, 20157 Milan, Italy; Unit of Nephrology and Dialysis, Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII, 24127 Bergamo, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, Italy; Corresponding author at: IRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’ - Centro Anna Maria Astori, Department of Molecular Medicine, Laboratory of Organ Regeneration, Science and Technology Park Kilometro Rosso, Via Stezzano, 87, 24126 Bergamo, Italy.The lack of engineering systems able to faithfully reproduce complex kidney structures in vitro has made it difficult to efficiently model kidney diseases and development. Using polydimethylsiloxane (PDMS) scaffolds and a kidney-derived cell line we developed a system to rapidly engineer custom-made 3D tubules with typical renal epithelial properties. This system was successfully employed to engineer patient-specific tubules, to model polycystic kidney disease (PKD) and test drug efficacy, and to identify a potential new pharmacological treatment. By optimizing our system we constructed functional ureteric bud (UB)-like tubules from human induced pluripotent stem cells (iPSCs), and identified a combination of growth factors that induces budding morphogenesis like embryonic kidneys do. Finally, we applied this assay to investigate budding defects in UB-like tubules derived from a patient with a PAX2 mutation.Our system enables the modeling of human kidney disease and development, drug testing and discovery, and lays the groundwork for engineering anatomically correct kidney tissues in vitro and developing personalized medicine applications. Keywords: Tubule engineering, Human pluripotent stem cells, Polycystic kidney disease, Ureteric bud, Drug discovery, PAX2http://www.sciencedirect.com/science/article/pii/S235239641830207X
collection DOAJ
language English
format Article
sources DOAJ
author Valentina Benedetti
Valerio Brizi
Patrizia Guida
Susanna Tomasoni
Osele Ciampi
Elena Angeli
Ugo Valbusa
Ariela Benigni
Giuseppe Remuzzi
Christodoulos Xinaris
spellingShingle Valentina Benedetti
Valerio Brizi
Patrizia Guida
Susanna Tomasoni
Osele Ciampi
Elena Angeli
Ugo Valbusa
Ariela Benigni
Giuseppe Remuzzi
Christodoulos Xinaris
Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery
EBioMedicine
author_facet Valentina Benedetti
Valerio Brizi
Patrizia Guida
Susanna Tomasoni
Osele Ciampi
Elena Angeli
Ugo Valbusa
Ariela Benigni
Giuseppe Remuzzi
Christodoulos Xinaris
author_sort Valentina Benedetti
title Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery
title_short Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery
title_full Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery
title_fullStr Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery
title_full_unstemmed Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery
title_sort engineered kidney tubules for modeling patient-specific diseases and drug discovery
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2018-07-01
description The lack of engineering systems able to faithfully reproduce complex kidney structures in vitro has made it difficult to efficiently model kidney diseases and development. Using polydimethylsiloxane (PDMS) scaffolds and a kidney-derived cell line we developed a system to rapidly engineer custom-made 3D tubules with typical renal epithelial properties. This system was successfully employed to engineer patient-specific tubules, to model polycystic kidney disease (PKD) and test drug efficacy, and to identify a potential new pharmacological treatment. By optimizing our system we constructed functional ureteric bud (UB)-like tubules from human induced pluripotent stem cells (iPSCs), and identified a combination of growth factors that induces budding morphogenesis like embryonic kidneys do. Finally, we applied this assay to investigate budding defects in UB-like tubules derived from a patient with a PAX2 mutation.Our system enables the modeling of human kidney disease and development, drug testing and discovery, and lays the groundwork for engineering anatomically correct kidney tissues in vitro and developing personalized medicine applications. Keywords: Tubule engineering, Human pluripotent stem cells, Polycystic kidney disease, Ureteric bud, Drug discovery, PAX2
url http://www.sciencedirect.com/science/article/pii/S235239641830207X
work_keys_str_mv AT valentinabenedetti engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery
AT valeriobrizi engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery
AT patriziaguida engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery
AT susannatomasoni engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery
AT oseleciampi engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery
AT elenaangeli engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery
AT ugovalbusa engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery
AT arielabenigni engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery
AT giusepperemuzzi engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery
AT christodoulosxinaris engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery
_version_ 1725420695249223680